ZENSUN SHANGHAI SCIENCE & TECHNOLOGY CO LTD has a total of 12 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PARANTA BIOSCIENCES LTD, NOVARTIS VACCINES AND DIAGNOSTICS S R L and HUNTER IMMUNOLOGY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Medical technology | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Foods | |
#6 | Natural saccharides | |
#7 | Syringes | |
#8 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Mingdong | 12 |
Publication | Filing date | Title |
---|---|---|
AU2014270882A1 | Extended release of neuregulin for treating heart failure |